Neosil Secures $10M in Funding
It’s a bumper month for companies doing research in the hair restoration arena. First Intercytex, then IGI, now Neosil.
Hercules Technology Growth Capital, Inc. has announced $10 million dollars in debt funding to Neosil.
“Hercules was particularly impressed with Neosil’s product pipeline and scope of therapeutics in development for an early stage pharmaceutical company,” said Kathy Conte, managing director of life sciences at Hercules. “We believe that the broad range of application and consumer driven need for both of Neosil’s current products will provide a number of opportunities for success within the industry.” (source)
Back in January, Neosil announced positive phase 2a clinical data for tests conducted on NEOSH101, a once daily topical treatment for androgenetic alopecia. The company is also developing a topical antimicrobial treatment.
Tags: alopecia, bald, baldness, hair-loss, hercules, hercules-technology-growth-capital, neosh101, neosilRelated Stories
POSTED IN: Bald Business, Bald Medicine
.gif)
0 opinions for Neosil Secures $10M in Funding
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: